Hm. Schatzl et al., DETECTION BY PCR OF HUMAN POLYOMAVIRUSES BK AND JC IN IMMUNOCOMPROMISED INDIVIDUALS AND PARTIAL SEQUENCING OF CONTROL REGIONS, Journal of medical virology, 42(2), 1994, pp. 138-145
Immunocompromised individuals were tested for the presence of the huma
n polyomaviruses JC (JCV) and BK (BKV) by the polymerase chain reactio
n (PCR). The use of appropriate primers in a nested PCR allowed the de
tection of both viruses simultaneously. Viruses were differentiated by
restriction fragment length analysis of amplified DNA fragments. Both
BKV and JCV DNA were detected in the urine of an AIDS patient with pr
ogressive multifocal leukencephalopathy. In autopsy materials from thi
s patient, JCV- but not BKV-DNA was found in brain and kidney tissue,
whereas lung tissue was negative for both virus DNAs. To evaluate the
methology further, hybridization-positive urines from three recipients
of bone marrow transplants and a positive urine of an acute myeloid l
eukemia patient were analyzed by this PCR method. One case was positiv
e both for BKV and JCV, two cases were positive only for BKV, and one
was negative for both. Parts of the control regions of JCV and BKV wer
e sequenced directly from PCR-derived fragments. The JCV sequence from
urine of the AIDS patient compared to sequences from a bone marrow tr
ansplant recipient and to archetypical reference strains showed two nu
cleotide (nt) exchanges out of 250 nt. The BKV sequences from the AML
and the AIDS patients showed five nt exchanges out of 265 nt in the co
ntrol region and were identified as BKV WW or WWT3 strains. In the agn
ogene region five exchanges were detected, two of them resulting in no
n-conservative amino acid exchanges. The possibility of testing clinic
al specimens of different origins by this PCR method is important for
elucidating often unclear clinical courses in immunocompromised patien
ts. Furthermore, our results show the versatility of PCR for diagnosis
and for molecular characterization of human polyomaviruses. (C) 1994
Wiley-Liss, Inc.